Skip to main
ORGS
ORGS logo

Orgenesis (ORGS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Orgenesis (ORGS) Stock

About Orgenesis (ORGS)

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferbe...read more
Market cap$7.62M
Yesterday's volume5.7K
Revenue (TTM)$899K
Avg. daily volume4.21K
EBITDA (TTM)-$24.05M
Open$1.40
Price / earnings ratio-0.16x
Yesterday's range$1.35 - $1.49
Debt / equity
52 week range$0.87 - $10.8
5 year debt / equity
Beta (LTM)0x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.07x
Ex-dividend date
Next earningsMar 3, 2025
Dividend payable date

Orgenesis Stock Rating

What analysts recommend for ORGS stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for Orgenesis stock is $7.63M

The current P/E ratio for Orgenesis stock is -0.16

The 52-week high for Orgenesis stock is $10.80. The current Orgenesis stock price $undefined is 100.00% below its 52-week high

The 52-week low for Orgenesis stock is $0.87. The current Orgenesis stock price $undefined has increased 100.00% from its 52-week low

No, the Orgenesis stock does not pay dividends to its shareholders

The target price for Orgenesis stock is $6 based on the average of what a group of analyst think Orgenesis stock could be worth at a future date. This is not a prediction by Public.com

How to buy Orgenesis stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Orgenesis stock

    Navigate to the Explore page. Then, type Orgenesis into the search bar. When you see Orgenesis stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Orgenesis stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Orgenesis Stock Earnings

The value each ORGS share was expected to gain vs. the value that each ORGS share actually gained.

Orgenesis (ORGS) reported Q3 2023 earnings per share (EPS) of -$4.30, missing estimates of $1 by 530.00%. In the same quarter last year, Orgenesis's earnings per share (EPS) was -$0.50. Orgenesis is expected to release next earnings on 03/03/2025, with an earnings per share (EPS) estimate of $0.

Buy Orgenesis (ORGS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.